Two-week Intensive Outpatient Trauma Treatment.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07565311

Enrollment

Registered

2026-05-04

Start date

2026-01-26

Completion date

2027-12-31

Last updated

2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder (PTSD)

Keywords

Intensive trauma treatment, qualitative study, EMDR, Prolonged exposure

Brief summary

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment.In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, men and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

Detailed description

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment. In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, males and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

Interventions

OTHERProlonged exposure and EMDR

Two-week intensive traume treatment

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* PTSD * 18-65 years * Able to give written informed consent.

Exclusion criteria

* Active substance abuse * psychotic or bipolar disorder * organic brain disorder * IQ\< 70 * Currently in a life-threating situation. * Serious suicide risk.

Design outcomes

Primary

Measure	Time frame	Description
Trauma symptom score as measured by International Trauma Questionnaire (ITQ)	12 weeks	ITQ: Higher score equals higher symptom load

Secondary

Measure	Time frame	Description
Function as measured by Work and social adjustment scale (WSAS)	12 weeeks	Higher scores equals poorer function

Countries

Norway

Contacts

CONTACTJulie H Evensen, MD PhD

uxevej@ous-hf.no004799339292

CONTACTVeronica Vaage-Kowalzik, MD

UXVAAG@ous-hf.no

PRINCIPAL_INVESTIGATORJulie H Evensen, MD PhD

Oslo University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026